Low Forced Expiratory Volume in Chronic Thromboembolic Pulmonary Hypertension
Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?
Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?
Is there a link between the severity and prognosis of chronic thromboembolic pulmonary hypertension and attenuated heart rate recovery at 1 minute?
A recent Chinese study sought to identify clinical predictors of pulmonary hypertension combined with obstructive sleep apnea.
Because oxidative stress and elevated ASK1 activity appear to play a role in vascular remodeling in PAH, ASK1 inhibition with selonsertib was studied.
A post-hoc analysis compared lung function changes in the INCREASE and TRIUMPH trials of inhaled treprostinil for PH-ILD and PAH.
A study investigated the efficacy of double or triple pharmacotherapy in pulmonary arterial hypertension.
Which inotropic agent should clinicians use in patients with cardiogenic shock, milirone or dobutamine?
Researchers examined the link between pulmonary hemodynamic variables and the presence of pericardial and pleural effusion.
Is the 2018 World Symposium on Pulmonary Hypertension definition of pre-capillary pulmonary hypertension beneficial in clinical practice?
AER-901 is an investigational drug-device combination therapy that consists of a nebulized formulation of imatinib and the Fox device, a breath-actuated smart nebulizer.